Results 21 to 30 of about 861,991 (266)
Leptin and leptin receptor expression as biomarkers for breast cancer: a retrospective study
BMC Cancer, 2023 Background Effective screening and treatment have reduced the number of women dying from breast cancer (BC). However, the long-term sequelae of BC treatment and psychosocial factors seriously affect the life quality of BC patients and survivors ...
Yan Wang +5 more
doaj +1 more source
Tumor Biology, 2003 Since 1996, the nine ISOBM Workshops have so far characterized more than 300 monoclonal antibodies to a variety of tumor markers that include CA125, AFP, PSA, MUC1, Cytokeratins, Sialyl Le(a), hCG, CEA, ALP, and more recently SCC, and S100. Besides the basic characterization of antibodies and their epitope configurations, several workshops have also ...
P D, Rye, K, Nustad, T, Stigbrand
openaire +2 more sources
Serum CA 15.3, CEA and ESR Patterns in Breast Cancer
The International Journal of Biological Markers, 1997 Serum CA 15.3, CEA and ESR were longitudinally determined in 298 patients with breast cancer during postsurgical follow-up and/or therapy. Observation lasted until the death of the patient or at least for three years.
M. Rubach +3 more
doaj +1 more source
Molecular & Cellular Proteomics, 2003 Abstract One of the questions most frequently asked of physicians by patients concerns prognosis. Markers of solid tumors are the best prognosticators of the course of these tumors. The effect of these markers on the host will have a substantial impact on prognosis by affecting the performance status of the patient.
Anne-Sofie Schrohl +6 more
openaire +2 more sources
Scientific Reports, 2021 An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Eduardo Martín‑Nares +6 more
doaj +1 more source
Clinical Behaviour of Prostatic Specific Antigen and Prostatic Acid Phosphatase: A Comparative Study
The International Journal of Biological Markers, 1989 We assayed prostatic specific antigen (PSA) and prostatic acid phosphatase (PAP) serum levels in 1383 patients using a double antibody radioimmunoassay (RIA) I 125 .
J. Morote Robles +3 more
doaj +1 more source
Calpains: Markers of tumor aggressiveness? [PDF]
Experimental Cell Research, 2010 Rhabdomyosarcoma (RMS) are soft-tissue sarcoma commonly encountered in childhood. RMS cells can acquire invasive behavior and form metastases. The metastatic dissemination implicates many proteases among which are mu-calpain and m-calpain. Study of calpain expression and activity underline the deregulation of calpain activity in RMS.
Roumes, Hélène +5 more
openaire +6 more sources
The International Journal of Biological Markers, 1992 Since 1987 we have been evaluating the cost/effectiveness ratio of tumor markers using carcinoembryonic antigen (CEA) as a leading indicator. Preliminary to the evaluation of cost/effectiveness ratio we verified the fitness of CEA requests to the proper ...
M. Gion +3 more
doaj +1 more source
Scientific Reports, 2021 The clinical utility of serum immunoglobulin free light chains (sFLC) in IgG4-related disease (IgG4-RD) is unknown. Herein we evaluated their association with clinical phenotypes, serology and activity in patients with IgG4-RD. Cross-sectional study that
Eduardo Martín-Nares +6 more
doaj +1 more source
Frontiers in Chemistry, 2023 Coronavirus pandemic has been a huge jeopardy to human health in various systems since it outbroke, early detection and prevention of further escalation has become a priority.
Qiuqi Zhang +4 more
doaj +1 more source